Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
CC-97540 are autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) that targets CD19, a cell surface tumor antigen, potentially leading to an immune response against CD19-expressing tumor cells and inducing cytotoxicity (NCI Drug Dictionary).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|